Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-31

Clinical Trial Update: A Pilot Study of Bevacizumab for Neoplastic Meningitis [Phase 1, Phase 2]

View source ↗

Summary

Pilot study evaluating bevacizumab for neoplastic meningitis completed; results posted after phases 1 and 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bevacizumab (bevacizumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Neoplastic Meningitis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-12-31